71
Views
8
CrossRef citations to date
0
Altmetric
Original Paper

Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse

&
Pages 237-242 | Accepted 28 Jul 2003, Published online: 12 Jul 2009

References

  • Blanchard JJ, Brown SE, Horan WP, Sherwood AR. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 2000;20(2):207–34.
  • Drake RE, Wallach MA, Teague GB, Freeman DH, Paskus TS, Clark TA. Housing instability and homelessness among rural schizophrenic patients. Am J Psychiatry 1991;148:330–6.
  • Soyka M, Albus M, Kathmann N, Finneli A, Hofstetter S, Holzbach R, et al. Prevalence of alcohol and drug abuse in schizophrenia inpatients. Eur Arch Psychiatry and Clin Neurosci 1993;242:362–72.
  • Seibyl JP, Satel SL, Anthony D, Southwick SM, Krystal JH, Chamey DS. Effects of cocaine on hospital course in
  • Kovasznay B, Fleisher J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull
  • Lieberman JA, Jody D, Greisler S, Vital-Herne J, Alvir JMJ, Walsleben J, Woemer MG. Treatment outcome of first episode
  • Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and course of recent-onset of schizophrenic disorders. Arch of Gen
  • Sokolski KN, Cummings JL, Abrams BI, DeMet EM, Katz LS, Costa JF. Effects of substance abuse on hallucinations rates and
  • Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davies JM Jr, Lewis DA. Predicting the "revolving door"
  • Brady KT, Killeen T, Jarrell P. Depression in alcoholic
  • Cuffel BJ, Chase P. Remission and relapse of substance use disorders in schizophrenia: Results from a one-year prospective
  • Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull1998;24:443–55.
  • Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees: Implications for public policy. Am Psychol
  • Cohen LJ, Tests MA, Brown RJ. Suicide and schizophrenia: Data from a prospective community treatment study. Am J Psychiatry 1990;147:602-7.1987;15:18-20.Psychiatry 1985;142: 1259–64.
  • Landmark J, Cernofsky ZZ, Merskey H. Correlates of suicideattempts and ideation in schizophrenia. Br J Psychiatry 1987;15: 18 –/20.
  • Khantzian E. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 1985;142: 1259–/64.
  • Khantzian EJ. The self-medication hypothesis of substance use disorders: A reconsideration and recent application. Harv Rev Psychiatry 1997;4: 231 –/44.
  • Freed EX. Alcoholism and schizophrenia: The search for perspectives. J Stud Alcohol 1975;36:853–/79. 20. Safer K. Substance abuse by young adult chronic patients. Hosp Community Psychiatry 1987;38: 511–/4.
  • Sevy S, Kay SR, Opler LA, van Praag HM. Significance of cocaine history in schizophrenia. J Nerv Ment Dis 1990;178: 642–/8.
  • Barbee JG, Clark PD, Crapanzano MS, Heinz GC, Kehoe CE. Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J Nerv Ment Dis 1989;177: 400–/7.
  • Cleghorn JM, Kaplan RD, Szechtman B, Brown GM, Franco S. Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. J Clin Psychiatry 1991;52: 26–/30.
  • Pulver AE, Wolyniec PC, Wagner MG, Moorman CC, Mc.Grath JA. An epidemiological investigation of alcohol-dependent schizophrenics. Acta Psychiatr Scand 1989;603–/12.
  • Soni SD, Bownlee M. Alcohol abuse in chronic schizophrenics: Implications for management in the community. Acta Psychiatr Scand 1991;84: 272–/6.
  • Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 1989;177: 408–/13.
  • Brunette MF, Mueser KT, Xie H, Drake RE. Relationships between symptoms of schizophrenia and substance abuse. J Nerv Ment Dis 1997;185: 13–/20.
  • Negrete JC, Knapp WP, Douglas DE, Smith WB. Cannabis affects the severity of schizophrenic symptoms: Results of a clinical survey. Psychol Med 1986;16: 515–/20.
  • Osher FC, Drake RE, Noordsy DL, Teague GB, Hurlbut SC, Biesanz JC, et al. Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry 1994;55: 109–/13.
  • Rosenthal RN, Hellerstein KJ, Miner CR. Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Compr Psychiatry 1994;35: 91–/8.
  • Alterman AI, Ayre FR, Williford WO. Diagnostic validation of conjoint schizophrenia and alcoholism. J Clin Psychiatry 1984;5: 300–/3.
  • Cuffel BJ, Heithoff KA, Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry 1993;44: 247–/51.
  • Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, et al. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr Bull 1990;16: 31–/56.
  • Serper MR, Alpert M, Ricardson NA, Dickson S, Allen MH, Werner A. Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry 1995;152: 1464–/9.
  • Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 1991;149: 224–/30.
  • Buckley P, Thompson P, Way L, Meltzer HY. Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy. Am J Psychiatry 1994;151: 385–/9.
  • Lysaker P, Bell M, Beam-Goulet J, Milstein R. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment Dis 1994;182: 109–/12.
  • Kay SR, Fizbein A, Opler LA. The Positive and Negative Symptom Scale (PANSS) for schizophrenia. Schizophr Bull 1987;2: 261–/76.
  • Mueser KT, Drake RE, Clark RE, McHugo GJ, Mercer-Mc Fadden C, Ackerson TH. Toolkit for evaluating substance abuse in person with severe mental illness. Cambridge, Massachusetts:Evaluation Center at Human Services Research Institute; 1995.
  • Barry KL, Fleming MF. The Alcohol Use Disorders Identification Test (AUDIT) and the SMAST-13: Predictive validity in a rural primary care sample. Alcohol Alcohol 1993;28: 33–/42.
  • Gavin R, Skinner HA. Diagnostic validity of the drug abuse screening test in assessment of DSM-III drug disorders. Brit J Addict 1989;84: 301–/7.
  • Drake RE, Alterman AI, Rosenberg SD. Detection of substance use disorders in severely mentally ill patients. Community Mental Health J 1993;29: 175–/92.
  • Staley D, El-Guebaly N. Psychometric properties of the drug abuse screening test in a psychiatric patient population. Addict Behav 1990;15: 257–/64.
  • Shaner A, Eckman TA, Roberts LJ, Wilkins JN, Tucker D, Tsuang JW, et al. Disability income, cocain use and repeated hospitalisation among schizophrenic cocain abusers: A government-sponsored revolving door? N Engl J Med 1995;333: 777–/83.
  • Bartels SJ, Drake RE, Wallach MA, Freeman DH. Characteristic hostility in schizophrenic outpatients. Schizophr Bull 1991;17: 163–/71.
  • Convit A, Nemes Z, Volavka J. History of phencyclidine use and repeated assaults in newly admitted young schizophrenic men. Am J Psychiatry 1988;145:1176.
  • Swanson JS, Holzer CE, Ganju VK, Jono RT. Violence and psychiatric disorder in the community: Evidence from the epide-miologic catchment area surveys. Hosp Community Psychiatry 1990;41:761–70.
  • Belcher JR. On becoming homeless: A study of chronically mentally ill persons. J Community Psychol 1989;17:173–85.
  • Weller MPI, Ang PC, Latimer-Sayer DT, Zachary A. Drug abuse and mental illness. Lancet 1988;1:997.
  • Silver H, Abboud E. Drug abuse in schizophrenia: Comparison of patients who began drug abuse before their first admission with those who began abusing drugs after their first admission. Schizophr Res 1994;13:57–63.
  • Allebeck P, Adamson C, Engstrom A, Rydberg U. Cannabis and schizophrenia:a longitudinal study of cases treated in Stockholm county. Acta Psychiatr Scand 1993;88:21–4.
  • Rabinowitz J, Bromet EJ, Lavelle J, Carlson G, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol Med 1998;28:1411–9.
  • Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Psychotogenic drug use and neuroleptic response. Schizophr Bull 1990;16:81–5.
  • Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L. Substance abuse and onset of psychotic illness. Hosp Commu-nity Psychiatry 1993;44:567–71.
  • Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. Acta Psychiatr Scand 1989;79:505–10.
  • Arndt S, Tyrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse in schizophrenia: The role of pre-morbid adjust-ment. Psychol Med 1992;22:379–88.
  • Breakey WR, Goodell H, Lorenz PC, McHugh PR. Hallucino-genic drugs as precipitants of schizophrenia. Psychol Med 1974;4:255–61.
  • Gershon ES, DeLisi LE, Hamovit J, Nurnberger JI, Maxwell ME, Schreiber J, et al. A controlled family study of chronic psychoses. Arch Gen Psychiatry 1988;45:328–36.
  • Hays P, Aidroos N. Alcoholism followed by schizophrenia. Acta Psychiatr Scand 1986;74:187–9.
  • Kendler KS. A twin study of individuals with both schizophrenia and alcoholism. Br J Psychiatry 1985;147:48–53.
  • Noordsy DL, Drake RE, Biesanz JC, McHugo GJ. Family history of alcoholism in schizophrenia. J Nerv Ment Disease 1994;182:651–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.